BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19462276)

  • 1. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients.
    Chiu YW; Chang JM; Hwang SJ; Tsai JC; Chen HC
    Ren Fail; 2009; 31(4):278-83. PubMed ID: 19462276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients].
    Corghi E; Patrosso C; Bamonti F; Baragetti I; Novembrino C; Lando G; De Franceschi M; Buccianti G
    G Ital Nefrol; 2002; 19(3):301-7. PubMed ID: 12195398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
    Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
    J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
    Yajnik CS; Lubree HG; Thuse NV; Ramdas LV; Deshpande SS; Deshpande VU; Deshpande JA; Uradey BS; Ganpule AA; Naik SS; Joshi NP; Farrant H; Refsum H
    Asia Pac J Clin Nutr; 2007; 16(1):103-9. PubMed ID: 17215186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Yango A; Shemin D; Hsu N; Jacques PF; Dworkin L; Selhub J; Bostom AG
    Kidney Int; 2001 Jan; 59(1):324-7. PubMed ID: 11135086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
    Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
    Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease.
    Hoffer LJ; Elian KM
    Clin Invest Med; 2004 Feb; 27(1):10-3. PubMed ID: 15061579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the homocysteine status in children with chronic renal failure.
    Farid FA; Faheem MS; Heshmat NM; Shaheen KY; Saad SS
    Am J Nephrol; 2004; 24(3):289-95. PubMed ID: 15087588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
    Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulphur amino acids, vitamin B12 and folic acid in children with chronic renal failure].
    Litwin M; Abuauba M; Wawer ZT; Grenda R; Kurył T; Pietraszek E
    Pol Merkur Lekarski; 2000 Apr; 8(46):268-9. PubMed ID: 10897644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
    Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN; Mamer OA; Hoffer LJ
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.